Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

ProQR Therapeutics N.V (PRQR) EBT Margin: 2021-2025

Historic EBT Margin for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to -381.89%.

  • ProQR Therapeutics N.V's EBT Margin fell 17091.00% to -381.89% in Q3 2025 from the same period last year, while for Sep 2025 it was -276.77%, marking a year-over-year decrease of 14142.00%. This contributed to the annual value of -147.90% for FY2024, which is 27908.00% up from last year.
  • According to the latest figures from Q3 2025, ProQR Therapeutics N.V's EBT Margin is -381.89%, which was down 19.86% from -318.60% recorded in Q2 2025.
  • In the past 5 years, ProQR Therapeutics N.V's EBT Margin ranged from a high of -45.87% in Q2 2024 and a low of -8,943.97% during Q1 2021.
  • For the 3-year period, ProQR Therapeutics N.V's EBT Margin averaged around -377.39%, with its median value being -223.04% (2025).
  • Within the past 5 years, the most significant YoY rise in ProQR Therapeutics N.V's EBT Margin was 769,530bps (2022), while the steepest drop was 113,034bps (2022).
  • Over the past 5 years, ProQR Therapeutics N.V's EBT Margin (Quarterly) stood at -7,622.59% in 2021, then skyrocketed by 577,537bps to -1,847.22% in 2022, then soared by 168,041bps to -166.81% in 2023, then crashed by 4,923bps to -216.04% in 2024, then crashed by 17,091bps to -381.89% in 2025.
  • Its EBT Margin was -381.89% in Q3 2025, compared to -318.60% in Q2 2025 and -223.04% in Q1 2025.